Outcomes of GLP-1 receptor agonist therapy in adults with sickle cell disease and type 2 diabetes: a real-world cohort analysis.

Orphanet J Rare Dis · 2026 · PMC13047803 · PMID 41904481

Europe PMC DOI

hedged sentence

0.1050

closest p · 2.1× alpha

0.1050

boldest claim

The sentences

did not reach statistical significanceP = 0.105not close (p > 0.1)

Although the point estimate favored GLP-1 RA use, this difference did not reach statistical significance (HR 0.63, 95% CI 0.36–1.10; P = 0.105) (Table 2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.